Expression of FCGR2A in the carcinoma of the bile duct, carcinoma of the esophagus, the glioblastoma multiforme, HNSC, the clear cell carcinoma of the kidney, renal papillary cell carcinoma, low-grade cerebral glioma, ovary serous cystadenocarcinoma, carcinoma of the pancreas, melanoma, and gastric cancer tissues was significantly higher than that of the corresponding adjacent tissues. Here, FCGR2A is linked to papillary renal cell carcinoma.